ImmunoGen Message Board - Msg: 31113351

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	5/19/2017 2:15:56 AM
	of 5665

Just a thought, now that IMGN is back above $5, will Institutional Investment grow dramatically greater. Many Institution's aren't supposed to invest in companies selling for under $5. I'm uncertain whether the high Institutional Ownership we've maintained may have been permitted to hold IMGN below $5 because they owned it when it was well above. Time will tell, but I believe that IMGN has only just begun a major news up that will see it at perhaps a quarter or more of the market cap of SGEN. Should IMGN have a new drug approved before SGEN's next approved drug, I'd not be at all surprised if IMGN's market cap exceeds that of SGEN. Based on current OS's and share prices, I believe that would price IMGN around $80 as it has substantially fewer shares outstanding. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next